IL-6 binds to the IL-6 receptor and then triggers the Janus kinase associated with the receptor, stimulating phosphorylation and activating signal transducer and activator of transcription 3 to initiate downstream angiogenesis, which leads to highly vascularized tumors and development of tumor occurrence. Here, IL6 is linked to neoplasm.